1. Introduction {#sec1-marinedrugs-18-00320}
===============

Marine-derived microorganisms are renowned for producing secondary metabolites, which have diverse structures and exhibit unexpected biological properties, making them excellent antitumor chemotherapy agents \[[@B1-marinedrugs-18-00320],[@B2-marinedrugs-18-00320],[@B3-marinedrugs-18-00320],[@B4-marinedrugs-18-00320]\]. To date, our group has published numerous papers featuring exploratory research on marine-derived fungal metabolites \[[@B5-marinedrugs-18-00320]\]. As part of this ongoing study, the metabolites of *Halosphaeriaceae* sp.---a fungus which was separated from the marine algae *Sargassum thunbergii*---were isolated and characterized. In this study, a new 14-membered macrodiolide was designated as halosmysin A (**1**), together with the known colletodiol (**2**) \[[@B6-marinedrugs-18-00320]\] from this fungal strain, ([Figure 1](#marinedrugs-18-00320-f001){ref-type="fig"}). Several related polyketide macrodiolides were isolated from diverse microorganisms, including **2**, colletoketol (grahamimysins A), colletoll, and colletallol from *Colletotrichum capsici* \[[@B6-marinedrugs-18-00320]\]; grahamimysins A~1~ and B from *Cytospora* sp. \[[@B7-marinedrugs-18-00320],[@B8-marinedrugs-18-00320],[@B9-marinedrugs-18-00320]\]; 9,10-dihydrocolletodiol from *Varicosporina ramulosa* \[[@B10-marinedrugs-18-00320]\]; clonostachydiol from *Clonostachys cylindrospora* \[[@B11-marinedrugs-18-00320]\]; *Gliocladium* sp. \[[@B12-marinedrugs-18-00320]\] and *Xylaria* sp. \[[@B13-marinedrugs-18-00320],[@B14-marinedrugs-18-00320]\]; 4-keto-clonostachydiol from *Gliocladium* sp. \[[@B12-marinedrugs-18-00320],[@B15-marinedrugs-18-00320]\]; cordybislactone from *Cordyceps* sp. \[[@B13-marinedrugs-18-00320]\]; and acremonol and acremodiol from an unidentified *Acremoniu*--like anamorphic fungus \[[@B16-marinedrugs-18-00320]\]. These macrodiolides exhibited diverse activities such as antimicrobial, antiosteoporosis, tyrosine kinase inhibition, anthelmintic, and cytotoxicity. Recently, other members of this family, namely acaulones, were isolated from the fungus *Acaulium* sp.; these acaulones possessed a new skeleton or functional group with the olefin moiety in the macrodiolide \[[@B17-marinedrugs-18-00320]\]. The stereostructures of these compounds were established by applying the several rules of chirality \[[@B6-marinedrugs-18-00320],[@B10-marinedrugs-18-00320]\], X-ray crystallographic analysis \[[@B18-marinedrugs-18-00320]\], and asymmetric total synthesis \[[@B19-marinedrugs-18-00320],[@B20-marinedrugs-18-00320],[@B21-marinedrugs-18-00320],[@B22-marinedrugs-18-00320],[@B23-marinedrugs-18-00320]\]. After revisions were conducted \[[@B10-marinedrugs-18-00320],[@B12-marinedrugs-18-00320],[@B13-marinedrugs-18-00320],[@B15-marinedrugs-18-00320]\], it was confirmed that these macrodiolides consisted of two unsymmetrical subunits, which were grouped into two different stereochemistries. The colletodiol-type compound possessed a 6*R*,14*R* configuration, whereas the clonostachydiol group adopted the opposite orientation ([Figure S1](#app1-marinedrugs-18-00320){ref-type="app"}). Additionally, these compounds had different skeletal number notations in the 14-membered ring.

Halosmysin A (**1**), which had a unique skeleton and possessed a thiosilvatin analogue conjugated to the 14-membered macrodiolide, might provide further information about the biological activity of this family, as well as its associated biosynthetic pathways. Herein, the structural determination of **1** was identified using ^1^H and ^13^C NMR spectroscopic techniques, while its stereochemistry was defined using NOESY data, information garnered from the *J* values in the ^1^H NMR spectrum, and a plausible biosynthesis from **2**. Since the elucidated stereochemistry of **1** was the same as that of **2**, we adopted the number notations of the 14-membered ring in colletodiol. Additionally, the cytotoxicity of these compounds was tested against murine P388 leukemia, human HL-60 leukemia, and murine L1210 leukemia cell lines.

2. Results and Discussion {#sec2-marinedrugs-18-00320}
=========================

This fungus was cultured in artificial seawater (80 L) for four weeks. After incubation, the EtOAc extract of the culture filtrate was purified via cytotoxic assay-directed fractionation using a silica gel column, followed by reverse-phase HPLC, affording halosmysin A (**1**) (3.2 mg, 0.11%) and colletodiol (**2**) (20.7 mg, 0.69%). Since the spectral data, including the specific rotation of **2**, were consistent with published reports \[[@B6-marinedrugs-18-00320],[@B10-marinedrugs-18-00320]\], **2** was identified as (6*R*,11*R*,12*R*,14*R*)-colletodiol. This section may be divided by subheadings. It should provide a concise and precise description of the experimental results, their interpretation, and the experimental conclusions which can be drawn therefrom.

Halosmysin A (**1**) was assigned the formula C~31~H~38~N~2~O~9~S using HRFABMS *m*/*z* 615.2380 \[M + H\]^+^ (calcd for C~31~H~39~N~2~O~9~S: 615.2376) ([Figure S8](#app1-marinedrugs-18-00320){ref-type="app"}). Absorption in the IR spectrum at 3393, 2930, 2862, 1752, 1706, 1657, and 1612 cm^−1^ indicated the presence of hydroxy, amido, and ester moieties, as well as an aromatic ring. Close inspection of the ^1^H and ^13^C NMR spectra ([Table 1](#marinedrugs-18-00320-t001){ref-type="table"} and [Table S1, Figures S2--S7](#app1-marinedrugs-18-00320){ref-type="app"}) of **1** using distortionless enhancement by polarization transfer (DEPT) and ^1^H--^13^C correlation spectroscopy (HSQC), revealed the presence of: two secondary methyls (C-15 and C-16); two olefinic methyls (C-15' and C-16'); one thiomethyl group (3'-SCH~3~); four sp^3^-hybridized methylenes (C-5, C-13, C-7', and C-12'), of which one was an oxygen-bearing sp^3^-methine (C-12'); five sp^3^-methines (C-6, C-9, C-10, C-12, and C-14), of which three were oxygen-bearing sp^3^-methines (C-6, C-12, and C-14); seven sp^2^-methines (C-3, C-4, C-9', C-10', and C-13'); two quaternary sp^3^-carbons (C-3', and C-6'); three quaternary sp^2^-carbons (C-8', C-11', and C-14'); and five carbonyl groups (C-2, C-8, C-11, C-2', and C-5'). In ^1^H--^1^H correlation spectroscopy (COSY), the correlations indicated in bold lines were observed, and five partial structures were elucidated ([Figure 2](#marinedrugs-18-00320-f002){ref-type="fig"}). Analysis of the HMBC spectrum showed the connection of these units with the remaining functional groups. The correlations from H-4 to C-2, from H-9 to C-8 and C-11, from H-10 to C-8, and from H-13 to C-11, confirmed the presence of the 14-membered bislactone moiety together with the ^1^H NMR chemical shifts at H-6 and H-14 (*δ* ppm 5.30 and 5.23, respectively) ([Figure 2](#marinedrugs-18-00320-f002){ref-type="fig"}, [Table S1](#app1-marinedrugs-18-00320){ref-type="app"}). The large coupling constant (*J*~3,4~ = 16.2 Hz) indicated that the geometrical configuration between C-3 and C-4 was *E*. This bislactone had the same planar structure as colletoketol \[[@B6-marinedrugs-18-00320]\] except for the saturated olefin between C-9 and C-10 ([Figure S1](#app1-marinedrugs-18-00320){ref-type="app"}). On the other hand, the HMBC correlations---from H-1' (NH) to C-3', from H-4' (NH) to C-2' and C-6', from S-CH~3~ to C-3', from H-7' to C-5', C-6', C-8', and C-9', from H-10' to C-8' and C-11', from H-12' to C-11' and C-14', and from H-15' and H-16' to C-13' and C-14'---confirmed the presence of the thiosilvatin analogue ([Figure 2](#marinedrugs-18-00320-f002){ref-type="fig"}, [Table S1](#app1-marinedrugs-18-00320){ref-type="app"}), which had been previously isolated from both *Tolypocladium* sp. \[[@B24-marinedrugs-18-00320]\] and *Fusarium* sp. \[[@B25-marinedrugs-18-00320],[@B26-marinedrugs-18-00320]\] as the 3,6-bis(methylthio)-2,5-piperazinedione derivative \[[@B27-marinedrugs-18-00320]\]. Additionally, the correlations from H-9 to C-6', from H-10 to C-3', and from H-7' to C-9, showed that the 14-membered bislactone moiety and the thiosilvatin analogue were bound between C-9 and C-6' and between C-10 and C-3' ([Figure 2](#marinedrugs-18-00320-f002){ref-type="fig"}, [Table S1](#app1-marinedrugs-18-00320){ref-type="app"}), thereby establishing the planar structure of **1**, as shown in [Figure 1](#marinedrugs-18-00320-f001){ref-type="fig"}.

For the stereochemistry of **1**, both the relative configuration and the conformation were investigated via nuclear Overhauser effect spectroscopy (NOESY) experiments and the ^1^H NMR coupling constant ([Table S1](#app1-marinedrugs-18-00320){ref-type="app"} and [Figure 3](#marinedrugs-18-00320-f003){ref-type="fig"}). All of the attempts to induce the crystallization of **1** were unsuccessful. For the 14-membered ring moiety of **1**, the NOESY correlations between H-3 and H-5 and those between H-4 and H-6, as well as the large coupling constants (*J*~5α,6~ = 13.2 Hz, *J*~5β,4~ = 10.2 Hz), confirmed the presence of dihedral angles between C-6 and C-5 and between C-5 and C-4 ([Figure 3](#marinedrugs-18-00320-f003){ref-type="fig"}; Newman projection formula A). On the other hand, the NOESY correlations from H-16 to H-13 and H-13, and the large coupling constants (*J*~13β,14~ = 12.0 Hz), revealed the dihedral angle between C-14 and C-13 ([Figure 3](#marinedrugs-18-00320-f003){ref-type="fig"}; Newman projection formula B). The NOESY correlations between H-3 and H-9, between H-9 and H-4' (NH), and between H-10 and H-4' (NH), showed that both H-9 and H-10 were oriented to the configuration. Additionally, the orientation for H-12 was deduced from the NOESY correlations between H-13 and H-10, and those between H-12 and 3'-SCH~3~, together with the small coupling constants (*J*~13α,12~ = 7.8 Hz, *J*~13β,12~ = 1.2 Hz). In the thiosilvatin analogue moiety, the NOESY correlations between H-4' (NH) and H-9, H-10, and 3'-SCH~3~, between H-12 and 3'-SCH~3~, between H-1' (NH) and H-7' and H-9', and between H-7' and H-9 and H-15, revealed the stereochemistry of C-3' and C-6'. Based on the evidence presented, the relative configuration of **1** was established ([Figure 1](#marinedrugs-18-00320-f001){ref-type="fig"}), which was the same as that of the other major co-metabolite from this fungus, colletodiol (**2**). Based on the information obtained from past synthetic studies about the stereochemistry of this class of 14-membered bislactones, we assumed that **1** belonged to the family of colletoketol, colletodiol (**2**), and grahamimycin B in terms of its absolute configuration, i.e., it possessed 6*R*,12*R*,14*R* ([Figure S1](#app1-marinedrugs-18-00320){ref-type="app"}) \[[@B10-marinedrugs-18-00320],[@B12-marinedrugs-18-00320],[@B13-marinedrugs-18-00320],[@B15-marinedrugs-18-00320],[@B19-marinedrugs-18-00320],[@B20-marinedrugs-18-00320],[@B21-marinedrugs-18-00320],[@B22-marinedrugs-18-00320],[@B23-marinedrugs-18-00320]\]. Confirmation of the absolute configuration of **1** was obtained through alkaline hydrolysis. As expected, the reaction produced (--)-5-hydroxy-(2*E*)-hexenoic acid, which corresponded to the triketide moiety of the same family of macrodiolides; confirmation of this was obtained from the ^1^H NMR spectrum and its specific rotation \[[@B6-marinedrugs-18-00320],[@B10-marinedrugs-18-00320]\].

Previous biosynthetic studies showed that colletodiol (**2**) was produced from the epoxide derivative (I) induced from the cyclic triene (II), which was formed via cyclization between the C~6~ precursor (III) and the C~8~ precursor (IV) \[[@B28-marinedrugs-18-00320],[@B29-marinedrugs-18-00320]\]. Additionally, oxygen-labeling experiments revealed that colletoketol was derived from **2** via the oxidative process \[[@B28-marinedrugs-18-00320]\]. Therefore, we hypothesized the biosynthetic pathway of **1** from colletoketol. Briefly, the 6-SCH~3~ group in the 3,6-bis(methylthio)-2,5-piperazinedione derivative (the thiosilvatin analogue) was eliminated as a result of the abstraction of an amide proton via enzymatic dehydrogenation. Subsequently, the *π*-electron at C-9 in the macrodiolide attacked C-6 in the thiosilvatin analogue as a nucleophile, forming a bond between C-9 and C-6' in **1**. Next, C-10 in the macrodiolide was attacked by C-3 in the piperazinedione, which eliminated a proton to form the bond between C-10 and C-3' in **1** ([Scheme 1](#marinedrugs-18-00320-sch001){ref-type="scheme"}). Since our hypothesis of the biosynthetic pathway suggests that stereoisomers of **1** at C-9, C-10, C-3', or C-6' exist, we will conduct further research to isolate and characterize the related metabolites from this fungus.

The cancer cell growth inhibitory properties of halosmysin A (**1**) and colletodiol (**2**) were examined using murine P388 leukemia, human HL-60 leukemia, and murine L1210 leukemia cell lines as a primary screen for antitumor activity ([Table 2](#marinedrugs-18-00320-t002){ref-type="table"}). According to the results, **1** exhibited a potency on par with that of 5-fluorouracil against the above-mentioned cell lines, whereas **2** did not inhibit cell growth at all. In a previous paper \[[@B25-marinedrugs-18-00320]\], the cytotoxicity of the thiosilvatin analogue was reported to be weak or inactive. Interestingly, the compound conjugated between the macrodiolide and the piperazinedione derivatives such as **1**, significantly inhibited the growth of cancer cell lines. Since there are no reports on macrodiolide bound to other molecules, the study of the structure--activity relationship is yet to begin. In order to examine the structure--activity relationship and elucidate details about the compound's mode of action, we will conduct further studies on related fungal metabolites, including the stereoisomers of **1**.

3. Materials and Methods {#sec3-marinedrugs-18-00320}
========================

3.1. General Experimental Procedures {#sec3dot1-marinedrugs-18-00320}
------------------------------------

The following procedures are the same as those in previous reports \[[@B5-marinedrugs-18-00320]\]. The NMR spectra were recorded on an Agilent-NMR-vnmrs (Agilent Technologies, Santa Clara, CA, USA) 600 with tetramethylsilane (TMS) as an internal reference. FABMS was recorded using a JEOL JMS-7000 mass spectrometer (JEOL, Tokyo, Japan). IR spectra were recorded on a JASCO FT/IR-680 Plus (Tokyo, Japan). Optical rotations were measured using a JASCO DIP-1000 digital polarimeter (Tokyo, Japan). Silica gel 60 (230--400 mesh, Nacalai Tesque, Inc., Kyoto, Japan) was used for column chromatography with medium pressure. ODS HPLC was run on a JASCO PU-1586 (Tokyo, Japan), equipped with a differential refractometer RI-1531 (Tokyo, Japan) and Cosmosil Packed Column 5C18-MSII (25 cm × 20 mm i.d., Nacalai Tesque, Inc., Kyoto, Japan). Analytical TLC was performed on precoated Merck aluminum sheets (DC-Alufolien Kieselgel 60 F254, 0.2 mm, Merck, Darmstadt, Germany) with the solvent system CH~2~Cl~2~--MeOH (19:1) (Nacalai Tesque, Inc., Kyoto, Japan), and compounds were viewed under a UV lamp (AS ONE Co., Ltd., Osaka, Japan) and sprayed with 10% H~2~SO~4~ (Nacalai Tesque, Inc., Kyoto, Japan), followed by heating.

3.2. Fungal Material {#sec3dot2-marinedrugs-18-00320}
--------------------

The fungus *Halosphaeriaceae* sp. was isolated from the surface of the marine alga *Sargassum thunbergii. Halosphaeriaceae* sp. was collected at Osaka Bay, Japan in July 2017. The fungal strain was identified based on the result of its internal transcribed spacer (ITS) rDNA nucleotide sequence analysis by Techno Suruga Laboratory Co., Ltd. (Shizuoka, Japan). The alga *Sargassum thunbergii* was wiped with EtOH and a cutting applied to the surface of the nutrient agar layered in a Petri dish. Serial transfers of one of the resulting colonies provided a pure strain of *Halosphaeriaceae* sp.

3.3. Culturing and Isolation of Metabolites {#sec3dot3-marinedrugs-18-00320}
-------------------------------------------

The fungus was cultured at 27 °C for four weeks in a medium (80 L) containing 1% glucose, 1% malt extract, and 0.05% peptone in artificial seawater adjusted to pH 7.5. Then, the culture filtrate was extracted thrice with AcOEt. The combined extracts were evaporated in vacuo to afford a mixture of crude metabolites (3.0 g). The EtOAc extract was chromatographed on a silica gel column, with a CH~2~Cl~2~/MeOH gradient as the eluent to afford Fr. 1 (2% MeOH in CH~2~Cl~2~ eluate, 121.2 mg). Fr. 1 was purified by ODS HPLC, using MeOH/H~2~O (70:30) as the eluent to afford **1** (3.2 mg) and **2** (20.7 mg).

Halosmysin A (**1**): pale yellow oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{22}^{D}$ +105.6 (*c* 0.048, CHCl~3~); IR (neat) *ν*~max~ / cm^−1^: 3193, 2930, 2862, 1722, 1706, 1657, 1612, 1510. HRFABMS *m*/*z* 615.2380 \[M + H\]^+^ (calcd for C~31~H~39~N~2~O~9~S: 615.2376); NMR data, see [Table 1](#marinedrugs-18-00320-t001){ref-type="table"} and [Table S1](#app1-marinedrugs-18-00320){ref-type="app"}.

3.4. Alkaline Hydrolysis of ***1*** {#sec3dot4-marinedrugs-18-00320}
-----------------------------------

First, **1** (2.8 mg) and 0.1 N NaOH aq. (1 mL) were stirred at room temperature for 15 h, then acidified with 1 N HCl and extracted with AcOEt. The organic layer was evaporated in vacuo, and the residue was purified by ODS HPLC, using MeOH/H~2~O (0.1% AcOH) (30:70) as the eluent to (--)-5-hydroxy-(2E)-hexenoic acid (0.9 mg) (r.t. 28.5 min).

(--)-5-hydroxy-(2E)-hexenoic acid: clear oil; $\left\lbrack \mathsf{\alpha} \right\rbrack_{22}^{D}$ -14.3 (c 0.09, EtOH); ^1^H NMR (600 MHz, MeOH-d~4~) δ ppm: 1.16 (3H, d, J = 6.0 Hz), 2.31 (2H, dd, J = 6.0, 6.0 Hz), 3.85 (1H, sext, J = 6.0 Hz), 5.92 (1H, br s), 6.88 (1H, m).

3.5. Assay for Cytotoxicity {#sec3dot5-marinedrugs-18-00320}
---------------------------

The cytotoxic activities of **1** and **2** were examined by the same procedure to date \[[@B5-marinedrugs-18-00320]\]---the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl- 2H-tetrazolium bromide (MTT) method. The P388, HL-60, and L1210 cells were cultured in an RPMI 1640 Medium (10% fetal calf serum) at 37 °C in 5% CO~2~. The test materials were dissolved in dimethyl sulfoxide (DMSO) to give a concentration of 10 mM, and the solution was diluted with the Essential Medium to yield concentrations of 200, 20, and 2 M, respectively. Each solution was combined with each cell suspension (1 × 10^−5^ cells/mL) in the medium, respectively. After incubating at 37 °C for 72 h in 5% CO~2~, the grown cells were labeled with 5 mg/mL MTT in phosphate-buffered saline (PBS), and the absorbance of formazan dissolved in 20% sodium dodecyl sulfate (SDS) in 0.1 N HCl, was measured at 540 nm with a microplate reader (MTP-310, CORONA electric). Each absorbance value was expressed as a percentage relative to that of the control cell suspension, which was prepared without the test substance, using the same procedure described above. All of the assays were performed three times, semilogarithmic plots were constructed from the averaged data, and the effective dose of the substance required to inhibit cell growth by 50% (IC~50~) was determined.

3.6. The Origin of the Cell Lines {#sec3dot6-marinedrugs-18-00320}
---------------------------------

The P388 cell line was obtained from Dr. Numata, the HL-60 cell line from Dr. Kawai (death), and the L1210 cell line from Dr. Endo.

4. Conclusions {#sec4-marinedrugs-18-00320}
==============

In conclusion, we have isolated a new macrodiolide, halosmysin A (**1**), as a structurally unprecedented secondary metabolite from the fungus *Halosphaeriaceae* sp., separated from the marine alga *Sargassum thunbergii.* In addition, we have proposed a plausible biosynthetic pathway toward **1** from the known macrodiolide, colletodiol (**2**), which was also isolated from the same fungal strain. This compound exhibited stronger cytotoxicity than **2** and the piperazinedione derivative, which were constituent molecules of **1**. In the near future, we will publish further research on the new, fused macrodiolides or the stereoisomer of **1**, to elucidate both the structure--activity relationship and the mechanism of activity.

We thank Endo (Kanazawa University) for the supply of cancer cells. We are grateful to M. Fujitake and K. Minoura of the same university for MS and NMR measurements, respectively.

The following are available online at <https://www.mdpi.com/1660-3397/18/6/320/s1>, Table S1: Spectral data including 2D NMR data for **1**, Figure S1: 14-membered macrodiolides associated to halosmysin A, Figure S2: ^1^H NMR spectrum of **1** in CDCl~3~, Figure S3: ^13^C NMR spectrum of **1** in CDCl~3~, Figure S4: ^1^H-^1^H COSY of **1**, Figure S5: NOESY of **1**, Figure S6: HMQC of **1**, Figure S7: HMBC of **1**, Figure S8: FABMS of **1**.
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![Structures of macrodiolides from *Halosphaeriaceae* sp.](marinedrugs-18-00320-g001){#marinedrugs-18-00320-f001}

![Key ^1^H-^1^H correlation spectroscopy (COSY) and HMBC correlations for **1.**](marinedrugs-18-00320-g002){#marinedrugs-18-00320-f002}

![Key NOESY correlations for **1.**](marinedrugs-18-00320-g003){#marinedrugs-18-00320-f003}

![Plausible biosynthetic pathway toward **1.**](marinedrugs-18-00320-sch001){#marinedrugs-18-00320-sch001}

marinedrugs-18-00320-t001_Table 1

###### 

NMR spectral data for **1** in CDCl~3~.**^b^**

  Position   δ~H~ ^a^       J/Hz   δ~C~                              Position   δ~H~ ^a^   J/Hz      δ~C~                               
  ---------- -------------- ------ --------------------------------- ---------- ---------- --------- ------ ------ ------------ ------- -------
  2                                                                  165.6      \(s\)      1' (NH)   5.73   s                           
  3          5.64           d      16.2 (4)                          125.3      \(d\)      2'                                   165.7   \(s\)
  4          6.78           ddd    16.2 (3), 10.2 (5β), 6.0 (5α)     143.5      \(d\)      3'                                   68.6    \(s\)
  5α         2.48           ddd    13.2 (5β), 6.0 (4), 1.2 (6)       39.0       \(t\)      4' (NH)   5.95   s                           
  5β         2.23           ddd    13.2 (5α), 13.2 (6), 10.2 (4)                           5'                                   170.9   \(s\)
  6          5.30           dqd    13.2 (5β), 6.0 (15), 1.2 (5α)     69.9       \(d\)      6'                                   63.7    \(s\)
  8                                                                  168.9      \(s\)      7'A       2.83   d      14.4 (7'B)   33.0    \(t\)
  9          3.38           d      3.0 (10)                          51.9       \(d\)      7'B       3.88   d      14.4 (7'A)           
  10         4.57           d      3.0 (9)                           51.0       \(d\)      8'                                   125.5   \(s\)
  11                                                                 208.2      \(s\)      9'        6.83   d      9.0 (10')    131.7   \(d\)
  12         4.55           d      7.8 (13α)                         75.6       \(d\)      10'       7.10   d      9.0 (9')     115.2   \(d\)
  13α        1.96           ddd    14.4 (13β), 7.8 (12), 3.0 (14)    37.4       \(t\)      11'                                  158.5   \(s\)
  13β        2.64           ddd    14.4 (13α), 12.0 (14), 1.2 (12)                         12'       4.47   d      7.2 (13')    64.8    \(t\)
  14         5.23           dqd    12.0 (13β), 6.0 (16), 3.0 (13α)   65.5       \(d\)      13'       5.47   br t   7.2 (12')    119.5   \(d\)
  15         1.44           d      6.0 (6)                           20.9       \(q\)      14'                                  138.4   \(s\)
  16         1.26           d      6.0 (14)                          20.2       \(q\)      15'       1.79   s                   25.8    \(q\)
  12-OH      Not observed                                                       16'        1.74      s             18.2         \(q\)   
                                                                                           S-CH~3~   2.25   s                   13.0    \(q\)

**^a^**^1^H chemical shift values (*δ* ppm from SiMe~4~) followed by multiplicity and then the coupling constants (J/Hz); **^b^** 600 MHz (^1^H NMR), 150 MHz (^13^C NMR).

marinedrugs-18-00320-t002_Table 2

###### 

Cytotoxicity of metabolites **1** and **2** against cancer cell lines.

  Compounds                Cell Line P388   Cell Line HL-60   Cell Line L1210
  ------------------------ ---------------- ----------------- -----------------
  **1**                    6.8 ± 1.1        2.2 ± 3.1         11.7 ± 2.8
  **2**                    \>300            \>300             \>300
  DMSO (control)           \>300            \>300             \>300
  5-fluorouracil **^b^**   3.9 ± 1.8        0.2 ± 2.5         0.2 ± 1.2

**^a^** DMSO was used as the vehicle; **^b^** Positive control.
